Radiolabeled antibodies in prostate cancer: A case study showing the effect of host immunity on antibody bio-distribution.
(2015) In Nuclear Medicine and Biology 42(4). p.375-380- Abstract
- Human tumors xenografted in immunodeficient mice are crucial models in nuclear medicine to evaluate the effectiveness of candidate diagnostic and therapeutic compounds. However, little attention has been focused on the biological profile of the host model and its potential effects on the bio-distribution and tumor targeting of the tracer compound under study. We specifically investigated the dissimilarity in bio-distribution of (111)In-DTPA-5A10, which targets free prostate specific antigen (fPSA), in two animal models.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/5040843
- author
- Vilhelmsson Timmermand, Oskar LU ; Santos, Elmer ; Thorek, Daniel L J ; Evans Axelsson, Susan LU ; Bjartell, Anders LU ; Lilja, Hans LU ; Larson, Steven M ; Strand, Sven-Erik LU ; Tran, Thuy LU and Ulmert, David LU
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Nuclear Medicine and Biology
- volume
- 42
- issue
- 4
- pages
- 375 - 380
- publisher
- Elsevier
- external identifiers
-
- pmid:25577038
- wos:000352182300007
- scopus:84924853675
- pmid:25577038
- ISSN
- 1872-9614
- DOI
- 10.1016/j.nucmedbio.2014.12.012
- language
- English
- LU publication?
- yes
- id
- 7d77cedd-f71c-42a5-a847-29a01bbc09bf (old id 5040843)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/25577038?dopt=Abstract
- date added to LUP
- 2016-04-01 10:22:09
- date last changed
- 2022-02-02 17:06:38
@article{7d77cedd-f71c-42a5-a847-29a01bbc09bf, abstract = {{Human tumors xenografted in immunodeficient mice are crucial models in nuclear medicine to evaluate the effectiveness of candidate diagnostic and therapeutic compounds. However, little attention has been focused on the biological profile of the host model and its potential effects on the bio-distribution and tumor targeting of the tracer compound under study. We specifically investigated the dissimilarity in bio-distribution of (111)In-DTPA-5A10, which targets free prostate specific antigen (fPSA), in two animal models.}}, author = {{Vilhelmsson Timmermand, Oskar and Santos, Elmer and Thorek, Daniel L J and Evans Axelsson, Susan and Bjartell, Anders and Lilja, Hans and Larson, Steven M and Strand, Sven-Erik and Tran, Thuy and Ulmert, David}}, issn = {{1872-9614}}, language = {{eng}}, number = {{4}}, pages = {{375--380}}, publisher = {{Elsevier}}, series = {{Nuclear Medicine and Biology}}, title = {{Radiolabeled antibodies in prostate cancer: A case study showing the effect of host immunity on antibody bio-distribution.}}, url = {{http://dx.doi.org/10.1016/j.nucmedbio.2014.12.012}}, doi = {{10.1016/j.nucmedbio.2014.12.012}}, volume = {{42}}, year = {{2015}}, }